Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Dermatology

Free Subscription Articles published in Cancer Lett Retrieve available abstracts of 52 articles: HTML format Text format

Single Articles

January 2012
1. NAOI Y , Tanei T, Kishi K, Tsunashima R, et al
   70-Gene classifier for differentiation between paclitaxel- and docetaxel-sensitive breast cancers.
   Cancer Lett. 2012;314:206-12.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. GREENBERG ES , Chong KK, Huynh KT, Tanaka R, et al
   Epigenetic Biomarkers in Skin Cancer.
   Cancer Lett. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. NYS K , Agostinis P
   Bcl-2 family members: essential players in skin cancer.
   Cancer Lett. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
4. ZENG W , Wan R, Zheng Y, Singh SR, et al
   Hypoxia, stem cells and bone tumor.
   Cancer Lett. 2011;313:129-36.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. DAI L , Qin Z, Defee M, Toole B, et al
   Kaposi sarcoma-associated herpesvirus (KSHV) induces a functional tumor-associated phenotype for oral fibroblasts.
   Cancer Lett. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. LIU KS , Liu H, Wang SX, Qi JH, et al
   SNX-2112, an Hsp90 inhibitor, induces apoptosis and autophagy via degradation of Hsp90 client proteins in human melanoma A-375 cells.
   Cancer Lett. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. PARK HJ , Kim SR, Kim MK, Choi KS, et al
   Neuromedin B receptor antagonist suppresses tumor angiogenesis and tumor growth in vitro and in vivo.
   Cancer Lett. 2011;312:117-27.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. GAUR S , Chen L, Yang L, Wu X, et al
   Inhibitors of mTOR overcome drug resistance from topoisomerase II inhibitors in solid tumors.
   Cancer Lett. 2011;311:20-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
9. VERGARA D , Valente CM, Tinelli A, Siciliano C, et al
   Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells.
   Cancer Lett. 2011;310:1-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. STEFFAN JJ , Koul HK
    Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor.
    Cancer Lett. 2011;310:109-17.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
11. DUNN JH , Ellis LZ, Fujita M
    Inflammasomes as molecular mediators of inflammation and cancer: Potential role in melanoma.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. SANCHEZ-HERNANDEZ I , Baquero P, Calleros L, Chiloeches A, et al
    Dual inhibition of (V600E)BRAF and the PI3K/AKT/mTOR pathway cooperates to induce apoptosis in melanoma cells through a MEK-independent mechanism.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
13. KIM S , Han J, Lee SK, Koo M, et al
    Smad7 acts as a negative regulator of the epidermal growth factor (EGF) signaling pathway in breast cancer cells.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. JANG SY , Jang SW, Ko J
    Regulation of ADP-ribosylation factor 4 expression by small leucine zipper protein and involvement in breast cancer cell migration.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. CHEN J , Liu L, Hou R, Shao Z, et al
    Calycosin promotes proliferation of estrogen receptor-positive cells via estrogen receptors and ERK1/2 activation in vitro and in vivo.
    Cancer Lett. 2011;308:144-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. PAN X , Han H, Wang L, Yang L, et al
    Nitidine Chloride inhibits breast cancer cells migration and invasion by suppressing c-Src/FAK associated signaling pathway.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. MANAVALAN TT , Teng Y, Appana SN, Datta S, et al
    Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. ZHAO Y , Wang Z, Jiang Y, Yang C, et al
    Inactivation of Rac1 reduces Trastuzumab resistance in PTEN deficient and insulin-like growth factor I receptor overexpressing human breast cancer SKBR3 cells.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. WEN G , Partridge MA, Li B, Hong M, et al
    TGFBI expression reduces in vitro and in vivo metastatic potential of lung and breast tumor cells.
    Cancer Lett. 2011;308:23-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
20. GREEN H , Stal O, Bachmeier K, Backlund LM, et al
    Pegylated liposomal doxorubicin as first-line monotherapy in elderly women with locally advanced or metastatic breast cancer: Novel treatment predictive factors identified.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. RUANO-RAVINA A , Cantero-Munoz P, Eraso Urien A
    Efficacy and safety of intraoperative radiotherapy in breast cancer: A systematic review.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. CHALKIADAKI G , Nikitovic D, Katonis P, Berdiaki A, et al
    Low molecular weight heparin inhibits melanoma cell adhesion and migration through a PKCa/JNK signaling pathway inducing actin cytoskeleton changes.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. SAMADI AK , Zhang X, Mukerji R, Donnelly AC, et al
    A novel C-terminal HSP90 inhibitor KU135 induces apoptosis and cell cycle arrest in melanoma cells.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. BENAD P , Rauner M, Rachner TD, Hofbauer LC, et al
    The anti-progestin RU-486 inhibits viability of MCF-7 breast cancer cells by suppressing WNT1.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. VAN RITE BD , Harrison RG
    Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine.
    Cancer Lett. 2011;307:53-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. RISINGER AL , Natarajan M, Thomas CR Jr, Mooberry SL, et al
    The taccalonolides, novel microtubule stabilizers, and gamma-radiation have additive effects on cellular viability.
    Cancer Lett. 2011;307:104-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
27. SCUDERI MR , Cantarella G, Scollo M, Lempereur L, et al
    The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. SEOL HJ , Jin J, Seong DH, Joo KM, et al
    Genetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancer.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. HERRMANN JL , Byekova Y, Elmets CA, Athar M, et al
    Liver kinase B1 (LKB1) in the pathogenesis of epithelial cancers.
    Cancer Lett. 2011;306:1-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
30. ZHANG JP , Qin HY, Wang L, Liang L, et al
    Overexpression of Notch ligand Dll1 in B16 melanoma cells leads to reduced tumor growth due to attenuated vascularization.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. HE JR , Tang LY, Yu DD, Su FX, et al
    Epstein-Barr virus and breast cancer: Serological study in a high-incidence area of nasopharyngeal carcinoma.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. ZHENG L , Yang W, Zhang C, Ding WJ, et al
    GDC-0941 sensitizes breast cancer to ABT-737 in vitro and in vivo through promoting the degradation of Mcl-1.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
33. LUAN Q , Sun J, Li C, Zhang G, et al
    Mutual enhancement between heparanase and vascular endothelial growth factor: A novel mechanism for melanoma progression.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. WU J , Omene C, Karkoszka J, Bosland M, et al
    Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. LOPEZ V , Foolad F, Kelleher SL
    ZnT2-overexpression represses the cytotoxic effects of zinc hyper-accumulation in malignant metallothionein-null T47D breast tumor cells.
    Cancer Lett. 2011;304:41-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
36. OSHIMA K , Naoi Y, Kishi K, Nakamura Y, et al
    Gene expression signature of TP53 but not its mutation status predicts response to sequential paclitaxel and 5-FU/epirubicin/cyclophosphamide in human breast cancer.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
37. HUANG X , Wang S, Lee CK, Yang X, et al
    HDAC inhibitor SNDX-275 enhances efficacy of trastuzumab in erbB2-overexpressing breast cancer cells and exhibits potential to overcome trastuzumab resistance.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. JUNG HJ , Suh SI, Suh MH, Baek WK, et al
    Pentamidine reduces expression of hypoxia-inducible factor-1alpha in DU145 and MDA-MB-231 cancer cells.
    Cancer Lett. 2011;303:39-46.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. BENES P , Knopfova L, Trcka F, Nemajerova A, et al
    Inhibition of topoisomerase IIalpha: novel function of wedelolactone.
    Cancer Lett. 2011;303:29-38.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
40. RAHIMI M , Toth TA, Tang CK
    CXCR4 suppression attenuates EGFRvIII-mediated invasion and induces p38 MAPK-dependent protein trafficking and degradation of EGFRvIII in breast cancer cells.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. GUO H , Li M, Chen P, Blake DJ, et al
    4-Methyl-3-nitro-benzoic acid, a migration inhibitor, prevents breast cancer metastasis in SCID mice.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. GARCIA-RIVERA D , Delgado R, Bougarne N, Haegeman G, et al
    Gallic acid indanone and mangiferin xanthone are strong determinants of immunosuppressive anti-tumour effects of Mangifera indica L. bark in MDA-MB231 breast cancer cells.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. ULDRICK TS , Whitby D
    Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. MAYER C , Popanda O, Greve B, Fritz E, et al
    A radiation-induced gene expression signature as a tool to predict acute radiotherapy-induced adverse side effects.
    Cancer Lett. 2011;302:20-8.
    PubMed     Text format     Related articles   
    
    
    
    February 2011
45. VAN RITE BD , Lazrak YA, Pagnon ML, Palwai NR, et al
    Enzyme prodrug therapy designed to target L-methioninase to the tumor vasculature.
    Cancer Lett. 2011;301:177-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
46. VERBEKE H , Struyf S, Berghmans N, Van Coillie E, et al
    Isotypic neutralizing antibodies against mouse GCP-2/CXCL6 inhibit melanoma growth and metastasis.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. SOLYOM S , Winqvist R, Nikkila J, Rapakko K, et al
    Screening for large genomic rearrangements in the FANCA gene reveals extensive deletion in a Finnish breast cancer family.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. SAADAT M , Khalili M, Omidvari S, Ansari-Lari M, et al
    Parental consanguineous marriages and clinical response to chemotherapy in locally advanced breast cancer patients.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. CHEN Y , Chen C, Yang B, Xu Q, et al
    Estrogen receptor-related genes as an important panel of predictors for breast cancer response to neoadjuvant chemotherapy.
    Cancer Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
50. HIPPOCRATE A , Oussaief L, Joab I
    Possible role of EBV in breast cancer and other unusually EBV-associated cancers.
    Cancer Lett. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. HE X , Wang Y, Zhu J, Orloff M, et al
    Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling.
    Cancer Lett. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. EHRENFELD P , Conejeros I, Pavicic MF, Matus CE, et al
    Activation of kinin B(1) receptor increases the release of metalloproteases-2 and -9 from both estrogen-sensitive and -insensitive breast cancer cells.
    Cancer Lett. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: